Unique ID issued by UMIN | UMIN000051901 |
---|---|
Receipt number | R000059225 |
Scientific Title | Safety and Efficacy of Acupuncture in Breast Cancer Survivors with Post-Mastectomy Pain Syndrome. |
Date of disclosure of the study information | 2023/08/14 |
Last modified on | 2023/08/15 14:00:02 |
Safety and Efficacy of Acupuncture in Breast Cancer Survivors with Post-Mastectomy Pain Syndrome.
ABC-1 study
Safety and Efficacy of Acupuncture in Breast Cancer Survivors with Post-Mastectomy Pain Syndrome.
ABC-1 study
Japan |
Post-Mastectomy Pain Syndrome
Hematology and clinical oncology | Breast surgery |
Malignancy
NO
To investigate the safety and efficacy of acupuncture in breast cancer survivors with post-mastectomy pain syndrome.
Safety,Efficacy
Exploratory
Change in pain intensity (NRS) between baseline and week 16.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
Acupuncture and moxibustion
18 | years-old | <= |
Not applicable |
Female
1) Patients with pathologically diagnosed Stage 1-3 breast cancer after radical surgery
2) Patients undergoing treatment-free follow-up at least 6 months after radical surgery without metastatic recurrence (patients on postoperative endocrine therapy or anti-HER2 therapy are included)
3) Postoperative average pain intensity (NRS) >= 4 over the past 24 hours in the chest, shoulder, or neck on the operated side
4) Age >= 18 years on the date of enrollment
5) ECOG PS 0 or 1 on the date of registration
6) Latest laboratory values within 28 days prior to enrollment (same day of the week 28 days prior to enrollment is acceptable) are
Neutrophils >= 1000/mcL, platelets >= 50,000/mcL
7) No change in pain medication* within 7 days prior to enrollment (same day of the week 7 days prior to enrollment is acceptable)
8) Patients who have given their free and voluntary consent in writing to participate in this study
1) Preoperative chest, shoulder, or neck pain on the operative side
2) Lymphedema in the upper extremity on the operative side
3) Bilateral chest, shoulder, or neck pain
4) Painful comorbidities such as fibromyalgia, inflammatory joint disease, etc.
5) Undergoing chemotherapy (excluding anti-HER2 therapy) or radiotherapy as of the date of registration
6) Has a psychiatric disorder such as severe depression (as determined by the attending physician)
7) Patients with serious complications (as determined by the attending physician)
8) Pregnant or lactating patients
9) Previous acupuncture treatment for PMPS
10) Patients currently enrolled in a clinical trial or a clinical trial affecting this study
11) Other patients deemed by the attending physician to be unsuitable for enrollment in the relevant clinical trial
30
1st name | Hiroto |
Middle name | |
Last name | Ishiki |
National Cancer Center Hospital
Department of Palliative Medicine
104-0045
5-1-1, Tsukiji, Chuoku, Tokyo, Japan
0335422511
hishiki@ncc.go.jp
1st name | Hiroto |
Middle name | |
Last name | Ishiki |
National Cancer Center Hospital
Department of Palliative Medicine
1040045
5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan
0335422511
hishiki@ncc.go.jp
National Cancer Center
Japan Agency for Meedical Research and Development
Japanese Governmental office
Ethical review board of the National Cancer Center
5-1-1, Tsukiji, Chuoku, Tokyo, Japan
0335422511
hishiki@ncc.go.jp
NO
2023 | Year | 08 | Month | 14 | Day |
Unpublished
Enrolling by invitation
2023 | Year | 07 | Month | 30 | Day |
2023 | Year | 08 | Month | 09 | Day |
2023 | Year | 08 | Month | 14 | Day |
2024 | Year | 03 | Month | 31 | Day |
2023 | Year | 08 | Month | 14 | Day |
2023 | Year | 08 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059225